Electronic monitoring of medication adherence in skin disease: results of a pilot study.
BACKGROUND
Traditional medication adherence monitoring for topical medication use in dermatology relies heavily on measures of self-reporting and ointment tube weight, which are susceptible to various biases.


METHODS
We first assessed the feasibility of using medication electronic monitoring system caps with cream, ointment, and gel formulations. We then performed a pilot study using 10 patients given a diagnosis of psoriasis with a weekly follow-up visit. Topical salicylic acid 6% was supplied to patients in medication jars with caps that recorded the opening and closing of the bottles, without patient knowledge.


RESULTS
Medication electronic monitoring system cap monitors accurately recorded the opening and closing of bottles of topical agents. Patients overreported adherence in patient logs, and there was greater detection of missed doses using electronic monitors than self-reporting through patient log (relative risk = 6.2, 95% confidence interval: 1.13, 34.09).


CONCLUSIONS
Electronic monitoring shows promise as a more accurate form of measuring treatment adherence to topical medication regimens.
D000287:Administration, Topical; D004349:Drug Packaging; D005240:Feasibility Studies; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage*; D010349:Patient Compliance; D010865:Pilot Projects; D020156:Salicylic Acid / Q000008:administration & dosage*; D012871:Skin Diseases / Q000188:drug therapy*
D007641:Keratolytic Agents; D020156:Salicylic Acid